314 related articles for article (PubMed ID: 33086062)
1. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
Maitituoheti M; Keung EZ; Tang M; Yan L; Alam H; Han G; Singh AK; Raman AT; Terranova C; Sarkar S; Orouji E; Amin SB; Sharma S; Williams M; Samant NS; Dhamdhere M; Zheng N; Shah T; Shah A; Axelrad JB; Anvar NE; Lin YH; Jiang S; Chang EQ; Ingram DR; Wang WL; Lazar A; Lee MG; Muller F; Wang L; Ying H; Rai K
Cell Rep; 2020 Oct; 33(3):108293. PubMed ID: 33086062
[TBL] [Abstract][Full Text] [Related]
2. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
Alam H; Tang M; Maitituoheti M; Dhar SS; Kumar M; Han CY; Ambati CR; Amin SB; Gu B; Chen TY; Lin YH; Chen J; Muller FL; Putluri N; Flores ER; DeMayo FJ; Baseler L; Rai K; Lee MG
Cancer Cell; 2020 Apr; 37(4):599-617.e7. PubMed ID: 32243837
[TBL] [Abstract][Full Text] [Related]
3.
Murugesan N; Maitituoheti M
Mol Cell Oncol; 2021; 8(5):1984827. PubMed ID: 34859145
[TBL] [Abstract][Full Text] [Related]
4. Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration.
Pacelli C; Adipietro I; Malerba N; Squeo GM; Piccoli C; Amoresano A; Pinto G; Pucci P; Lee JE; Ge K; Capitanio N; Merla G
Cells; 2020 Jul; 9(7):. PubMed ID: 32668765
[No Abstract] [Full Text] [Related]
5. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
Li M; Shi M; Xu Y; Qiu J; Lv Q
Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
[TBL] [Abstract][Full Text] [Related]
6. Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation.
Wright A; Hall A; Daly T; Fontelonga T; Potter S; Schafer C; Lindsley A; Hung C; Bodamer O; Gussoni E
FASEB J; 2021 Nov; 35(11):e21955. PubMed ID: 34613626
[TBL] [Abstract][Full Text] [Related]
7. Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome.
Carosso GA; Boukas L; Augustin JJ; Nguyen HN; Winer BL; Cannon GH; Robertson JD; Zhang L; Hansen KD; Goff LA; Bjornsson HT
JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31465303
[TBL] [Abstract][Full Text] [Related]
8. COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer.
Fagan RJ; Dingwall AK
Cancer Lett; 2019 Aug; 458():56-65. PubMed ID: 31128216
[TBL] [Abstract][Full Text] [Related]
9. KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.
Sun P; Wu T; Sun X; Cui Z; Zhang H; Xia Q; Zhang D
Biomed Pharmacother; 2019 Jul; 115():108924. PubMed ID: 31100540
[TBL] [Abstract][Full Text] [Related]
10. H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation.
Kubo N; Chen PB; Hu R; Ye Z; Sasaki H; Ren B
Mol Cell; 2024 May; 84(9):1742-1752.e5. PubMed ID: 38513661
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes.
Wang J; Duan Z; Nugent Z; Zou JX; Borowsky AD; Zhang Y; Tepper CG; Li JJ; Fiehn O; Xu J; Kung HJ; Murphy LC; Chen HW
Cancer Lett; 2016 Aug; 378(2):69-79. PubMed ID: 27164560
[TBL] [Abstract][Full Text] [Related]
12. KMT2D deficiency disturbs the proliferation and cell cycle activity of dental epithelial cell line (LS8) partially via Wnt signaling.
Pang L; Tian H; Gao X; Wang W; Wang X; Zhang Z
Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34724040
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk.
Wang Q; Trevino LS; Wong RL; Medvedovic M; Chen J; Ho SM; Shen J; Foulds CE; Coarfa C; O'Malley BW; Shilatifard A; Walker CL
Mol Endocrinol; 2016 Aug; 30(8):856-71. PubMed ID: 27219490
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production.
Ter Braak B; Siezen CL; Lee JS; Rao P; Voorhoeve C; Ruppin E; van der Laan JW; van de Water B
Breast Cancer Res; 2017 Feb; 19(1):14. PubMed ID: 28173837
[TBL] [Abstract][Full Text] [Related]
15. Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.
Koutsioumpa M; Hatziapostolou M; Polytarchou C; Tolosa EJ; Almada LL; Mahurkar-Joshi S; Williams J; Tirado-Rodriguez AB; Huerta-Yepez S; Karavias D; Kourea H; Poultsides GA; Struhl K; Dawson DW; Donahue TR; Fernández-Zapico ME; Iliopoulos D
Gut; 2019 Jul; 68(7):1271-1286. PubMed ID: 30337373
[TBL] [Abstract][Full Text] [Related]
16. Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome.
Pilarowski GO; Cazares T; Zhang L; Benjamin JS; Liu K; Jagannathan S; Mousa N; Kasten J; Barski A; Lindsley AW; Bjornsson HT
J Allergy Clin Immunol; 2020 Mar; 145(3):982-992. PubMed ID: 31816409
[TBL] [Abstract][Full Text] [Related]
17. Loss of Histone Methyltransferase KMT2D Attenuates Angiogenesis in the Ischemic Heart by Inhibiting the Transcriptional Activation of VEGF-A.
Meng XM; Liu SB; Deng T; Li DY; You L; Hong H; Feng QP; Zhu BM
J Cardiovasc Transl Res; 2023 Oct; 16(5):1032-1049. PubMed ID: 36947365
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern of Kmt2d in murine craniofacial tissues.
Dong C; Umar M; Bartoletti G; Gahankari A; Fidelak L; He F
Gene Expr Patterns; 2019 Dec; 34():119060. PubMed ID: 31228576
[TBL] [Abstract][Full Text] [Related]
19. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation.
Guo C; Chen LH; Huang Y; Chang CC; Wang P; Pirozzi CJ; Qin X; Bao X; Greer PK; McLendon RE; Yan H; Keir ST; Bigner DD; He Y
Oncotarget; 2013 Nov; 4(11):2144-53. PubMed ID: 24240169
[TBL] [Abstract][Full Text] [Related]
20. Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors.
Morcillo-Garcia S; Noblejas-Lopez MDM; Nieto-Jimenez C; Perez-Peña J; Nuncia-Cantarero M; Győrffy B; Amir E; Pandiella A; Galan-Moya EM; Ocana A
PLoS One; 2019; 14(4):e0209134. PubMed ID: 30990809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
